ÂÜÀòÂÒÂ×

Kevin joined in 2021 to lead Chemistry, Manufacturing and Controls (CMC) and Quality Operations. He has over 20 years of experience in the development and manufacture of RNA oligonucleotide medicines at Nitto Denko Avecia, RXi Pharmaceuticals, Galena Biopharma, Dicerna Pharmaceuticals and most recently as an independent consultant. He gained his PhD in Organic Synthesis from the University of London. Kevin is based in Massachusetts USA.